1. Andreasen F, Boye E, Christoffersen E, Dalsgaard P, Henneberg E, Kallenbach A, Ladefoged S, Lillquist K, Mikkelsen E, Nordero E, Olsen J, Pedersen JK, Pedersen V, Bruun Pedersen G, Schroll J, Schulz H, Seidelin J (1975) Assessment of verapamil in the treatment of angina pectoris. Eur J Cardiol 2:443?452
2. Bender F (1970) Die Behandlung tachykarder Arrhythmien und der arteriellen Hypertonie mit Verapamil. Arzneim Forsch 20:1310?1325
3. Eichelbaum M, Somogyi A, Unruh von GE, Dengler HJ (1980a) Simultaneous determination of the i.v. and oral pharmaeokinetic parameters of D,L-verapamil using stable labelled verapamil. Eur J Clin Pharmacol (submitted for publication)
4. Eichelbaum M, Somogyi A, Unruh GE von, Dengler HJ (1980b) Superiority of stable labelled techniques in the bioavailability assessment of drugs undergoing extensive first pass elimination. Studies on the relative bioavailability of verapamil tablets. Eur J Clin Pharmacol (submitted for publication)
5. Eichelbaum M, Ende M, Remberg G, Schomerus M, Dengler HJ (1979) The metabolism of D,L-(14C)verapamil in man. Drug Metab Dispos 7:145?148